TY - STD TI - Araki Y, Mimura T. The mechanisms underlying chronic inflammation in rheumatoid arthritis from the perspective of the epigenetic landscape. J Immunol Res. 2016:6290682. https://doi.org/10.1155/2016/6290682. ID - ref1 ER - TY - JOUR AU - Spindler, A. AU - Bellomio, V. AU - Berman, A. AU - Lucero, E. AU - Baigorria, M. AU - Paz, S. PY - 2002 DA - 2002// TI - Prevalence of rheumatoid arthritis in Tucuman JO - Argentina J Rheumatol VL - 29 ID - Spindler2002 ER - TY - JOUR AU - Pelaez-Ballestas, I. AU - Sanin, L. H. AU - Moreno-Montoya, J. AU - Alvarez-Nemegyei, J. AU - Burgos-Vargas, R. AU - Garza-Elizondo, M. PY - 2011 DA - 2011// TI - Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology JO - J Rheumatol Suppl VL - 86 UR - https://doi.org/10.3899/jrheum.100951 DO - 10.3899/jrheum.100951 ID - Pelaez-Ballestas2011 ER - TY - JOUR AU - Marques-Neto, J. F. AU - Gonçalves, E. T. AU - Langen, L. F. O. B. AU - Cunha, M. F. L. AU - Radominski, S. AU - Oliveira, S. M. PY - 1993 DA - 1993// TI - Multicentric study of the prevalence of adult rheumatoid arthritis in Brazilian population samples JO - Rev Bras Reumatol VL - 33 ID - Marques-Neto1993 ER - TY - JOUR AU - Senna, E. R. AU - Barros, A. L. AU - Silva, E. O. AU - Costa, I. F. AU - Pereira, L. V. AU - Ciconelli, R. M. PY - 2004 DA - 2004// TI - Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach JO - J Rheumatol VL - 31 ID - Senna2004 ER - TY - STD TI - Meroni PL, Zavaglia D, Girmenia C. Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol. 2017;36:317-28. ID - ref6 ER - TY - JOUR AU - Muniz, L. F. AU - Silva, C. R. AU - Costa, T. F. AU - Mota, L. M. PY - 2014 DA - 2014// TI - Vaccination in patients from Brasilia cohort with early rheumatoid arthritis JO - Rev Bras Reumatol VL - 54 UR - https://doi.org/10.1016/j.rbr.2014.04.002 DO - 10.1016/j.rbr.2014.04.002 ID - Muniz2014 ER - TY - JOUR AU - Friedman, M. A. AU - Winthrop, K. L. PY - 2017 DA - 2017// TI - Vaccines and disease-modifying antirheumatic drugs: practical implications for the rheumatologist JO - Rheum Dis Clin N Am VL - 43 UR - https://doi.org/10.1016/j.rdc.2016.09.003 DO - 10.1016/j.rdc.2016.09.003 ID - Friedman2017 ER - TY - JOUR AU - Goldani, L. Z. PY - 2017 DA - 2017// TI - Yellow fever outbreak in Brazil, 2017 JO - Braz J Infect Dis VL - 21 UR - https://doi.org/10.1016/j.bjid.2017.02.004 DO - 10.1016/j.bjid.2017.02.004 ID - Goldani2017 ER - TY - JOUR AU - Ortiz-Martinez, Y. AU - Patino-Barbosa, A. M. AU - Rodriguez-Morales, A. J. PY - 2017 DA - 2017// TI - Yellow fever in the Americas: the growing concern about new epidemics JO - F1000Res VL - 6 UR - https://doi.org/10.12688/f1000research.11280.1 DO - 10.12688/f1000research.11280.1 ID - Ortiz-Martinez2017 ER - TY - JOUR AU - Simoes, M. AU - Camacho, L. A. AU - Yamamura, A. M. AU - Miranda, E. H. AU - Cajaraville, A. C. AU - Silva-Freire, M. PY - 2012 DA - 2012// TI - Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies JO - Biologicals VL - 40 UR - https://doi.org/10.1016/j.biologicals.2012.09.005 DO - 10.1016/j.biologicals.2012.09.005 ID - Simoes2012 ER - TY - JOUR AU - Miyaji, K. T. AU - Avelino-Silva, V. I. AU - Simoes, M. AU - Freire, M. D. AU - Medeiros, C. R. AU - Braga, P. E. PY - 2017 DA - 2017// TI - Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults JO - Rev Inst Med Trop S Paulo VL - 59 UR - https://doi.org/10.1590/s1678-9946201759002 DO - 10.1590/s1678-9946201759002 ID - Miyaji2017 ER - TY - JOUR AU - Campi-Azevedo, A. C. AU - Costa-Pereira, C. AU - Antonelli, L. R. AU - Fonseca, C. T. AU - Teixeira-Carvalho, A. AU - Villela-Rezende, G. PY - 2016 DA - 2016// TI - Booster dose after 10 years is recommended following 17DD-YF primary vaccination JO - Hum Vaccin Immunother VL - 12 UR - https://doi.org/10.1080/21645515.2015.1082693 DO - 10.1080/21645515.2015.1082693 ID - Campi-Azevedo2016 ER - TY - JOUR AU - Luiza-Silva, M. AU - Campi-Azevedo, A. C. AU - Batista, M. A. AU - Martins, M. A. AU - Avelar, R. S. AU - Silveira- Lemos, D. PY - 2011 DA - 2011// TI - Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody JO - J Infect Dis VL - 204 UR - https://doi.org/10.1093/infdis/jir439 DO - 10.1093/infdis/jir439 ID - Luiza-Silva2011 ER - TY - STD TI - Costa-Pereira C, Campi-Azevedo AC, Coelho-dos-Reis JG, Peruhype-Magalhāes V, Araújo MSS, Antonelli LRV, et al. Multi-parameter approach to evaluate the timing of memory status after primary 17DD-YF vaccination. PLoS Negl Trop Dis. 2018. https://doi.org/10.1371/journal.pntd.0006462. ID - ref15 ER - TY - STD TI - Watson AM, Klimstra WB. T cell-mediated immunity towards yellow fever virus and useful animal models. Viruses. 2017;9. https://doi.org/10.3390/v9040077. ID - ref16 ER - TY - JOUR AU - Mason, R. A. AU - Tauraso, N. M. AU - Spertzel, R. O. AU - Ginn, R. K. PY - 1973 DA - 1973// TI - Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine JO - Appl Microbiol VL - 25 ID - Mason1973 ER - TY - JOUR AU - Julander, J. G. AU - Trent, D. W. AU - Monath, T. P. PY - 2011 DA - 2011// TI - Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model JO - Vaccine VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.06.034 DO - 10.1016/j.vaccine.2011.06.034 ID - Julander2011 ER - TY - JOUR AU - Camacho, L. A. AU - Freire, M. S. AU - Leal, M. L. AU - Aguiar, S. G. AU - Nascimento, J. P. AU - Iguchi, T. PY - 2004 DA - 2004// TI - Immunogenicity of WHO-17D and brazilian 17DD yellow fever vaccines: a randomized trial JO - Rev Saude Publica VL - 38 UR - https://doi.org/10.1590/S0034-89102004000500009 DO - 10.1590/S0034-89102004000500009 ID - Camacho2004 ER - TY - JOUR AU - Niedrig, M. AU - Lademann, M. AU - Emmerich, P. AU - Lafrenz, M. PY - 1999 DA - 1999// TI - Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA JO - Tropical Med Int Health VL - 4 UR - https://doi.org/10.1046/j.1365-3156.1999.00496.x DO - 10.1046/j.1365-3156.1999.00496.x ID - Niedrig1999 ER - TY - JOUR PY - 2014 DA - 2014// TI - Duration of post-vaccination immunity against yellow fever in adults JO - Vaccine VL - 32 UR - https://doi.org/10.1016/j.vaccine.2014.07.021 DO - 10.1016/j.vaccine.2014.07.021 ID - ref21 ER - TY - JOUR AU - Miller, J. D. AU - Most, R. G. AU - Akondy, R. S. AU - Glidewell, J. T. AU - Albott, S. AU - Masopust, D. PY - 2008 DA - 2008// TI - Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines JO - Immunity VL - 28 UR - https://doi.org/10.1016/j.immuni.2008.02.020 DO - 10.1016/j.immuni.2008.02.020 ID - Miller2008 ER - TY - JOUR AU - Akondy, R. S. AU - Monson, N. D. AU - Miller, J. D. AU - Edupuganti, S. AU - Teuwen, D. AU - Wu, H. PY - 2009 DA - 2009// TI - The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response JO - J Immunol VL - 183 UR - https://doi.org/10.4049/jimmunol.0803903 DO - 10.4049/jimmunol.0803903 ID - Akondy2009 ER - TY - JOUR AU - Blom, K. AU - Braun, M. AU - Ivarsson, M. A. AU - Gonzalez, V. D. AU - Falconer, K. AU - Moll, M. PY - 2013 DA - 2013// TI - Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response JO - J Immunol VL - 190 UR - https://doi.org/10.4049/jimmunol.1202234 DO - 10.4049/jimmunol.1202234 ID - Blom2013 ER - TY - JOUR AU - Martins, M. A. AU - Silva, M. L. AU - Marciano, A. P. AU - Peruhype-Magalhaes, V. AU - Eloi-Santos, S. M. AU - Ribeiro, J. G. PY - 2007 DA - 2007// TI - Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization? JO - Clin Exp Immunol VL - 148 UR - https://doi.org/10.1111/j.1365-2249.2006.03317.x DO - 10.1111/j.1365-2249.2006.03317.x ID - Martins2007 ER - TY - JOUR AU - Neves, P. C. AU - Matos, D. C. AU - Marcovistz, R. AU - Galler, R. PY - 2009 DA - 2009// TI - TLR expression and NK cell activation after human yellow fever vaccination JO - Vaccine VL - 27 UR - https://doi.org/10.1016/j.vaccine.2009.07.028 DO - 10.1016/j.vaccine.2009.07.028 ID - Neves2009 ER - TY - JOUR AU - Silva, M. L. AU - Espirito-Santo, L. R. AU - Martins, M. A. AU - Silveira-Lemos, D. AU - Peruhype-Magalhaes, V. AU - Caminha, R. C. PY - 2011 DA - 2011// TI - Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults JO - Vaccine VL - 29 UR - https://doi.org/10.1016/j.vaccine.2010.08.046 DO - 10.1016/j.vaccine.2010.08.046 ID - Silva2011 ER - TY - JOUR AU - Silva, M. L. AU - Espirito-Santo, L. R. AU - Martins, M. A. AU - Silveira-Lemos, D. AU - Peruhype-Magalhaes, V. AU - Caminha, R. C. PY - 2010 DA - 2010// TI - Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination JO - Clin Vaccine Immunol VL - 17 UR - https://doi.org/10.1128/CVI.00369-09 DO - 10.1128/CVI.00369-09 ID - Silva2010 ER - TY - JOUR AU - Rakoczi, E. AU - Szekanecz, Z. PY - 2017 DA - 2017// TI - Pneumococcal vaccination in autoimmune rheumatic diseases JO - RMD Open VL - 3 UR - https://doi.org/10.1136/rmdopen-2017-000484. DO - 10.1136/rmdopen-2017-000484. ID - Rakoczi2017 ER - TY - JOUR AU - Rubin, L. G. AU - Levin, M. J. AU - Ljungman, P. AU - Davies, E. G. AU - Avery, R. AU - Tomblyn, M. PY - 2014 DA - 2014// TI - 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host JO - Clin Infect Dis VL - 58 UR - https://doi.org/10.1093/cid/cit816 DO - 10.1093/cid/cit816 ID - Rubin2014 ER - TY - JOUR AU - Gabay, C. AU - Bel, M. AU - Combescure, C. AU - Ribi, C. AU - Meier, S. AU - Posfay-Barbe, K. PY - 2011 DA - 2011// TI - Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study JO - Arthritis Rheum VL - 6 UR - https://doi.org/10.1002/art.30325 DO - 10.1002/art.30325 ID - Gabay2011 ER - TY - JOUR AU - McMahan, Z. H. AU - Bingham, C. O. PY - 2014 DA - 2014// TI - Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases JO - Arthritis Res Ther VL - 16 UR - https://doi.org/10.1186/s13075-014-0506-0 DO - 10.1186/s13075-014-0506-0 ID - McMahan2014 ER - TY - STD TI - Sociedade Brasileira de Reumatologia. Nota técnica SBR/SBIm/SBI/SBMT: vacina febre amarela em pacientes reumáticos - 31/01/2018. [Portuguese]. 2018. Available from: https://sbim.org.br/images/files/nt-fa-reumato-sbr-sbim-sbi-sbmt-180131.pdf. Accessed 2 July 2018. UR - https://sbim.org.br/images/files/nt-fa-reumato-sbr-sbim-sbi-sbmt-180131.pdf ID - ref33 ER -